Listed in year 2004, Living Cell Technologies Limited (ASX: LCT) is a cell therapy based company that is working towards neurodegenerative diseases. The Australasian company is emerging as a biotech player that aims to develop and commercialize regenerative treatments and its lead product, known as NTCELL®, is an alginate coated capsule that has clusters of neonatal porcine choroid plexus cells to help growth and repair nerve degeneration.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site
we will assume that you are happy with it.